Reliq Health Technologies (RHT.V) – Lytham Partners Fall 2022 Investor Conference highlights

Yesterday (September 28, 2022), Lytham Partners hosted RHT.V CEO Lisa Crossley at their Fall 2022 Investor Conference taking place on September 28 and 29, 2022.  She presented the company to participants and responded to a number of questions.  Here are extracts from comments made by Lisa Crossley that should be of interest to investors:

Reliq Health Technologies (RHT.V) – Thoughts on the Q2 FY2022 financials

RHT.V has just (March 1, 2022) released its latest interim financials and Management Discussion and Analysis for the period ended December 31, 2021 (Q2 FY2022). Here are the points that stand out, in our opinion:

Understanding the potential of telemedicine

Telemedicine, with the potential to improve patient health outcomes and quality of life, as well as reduce spiralling health costs, is a hot topic, with companies providing services in this space attracting more attention. But what exactly does growth look like in this sector?

Reliq Health Technologies (RHT.V) – Reflecting back on 2021

In our second annual review of our top recommendation (although we have been covering RHT.V at themoneynarrative since 2017), let’s look at what we have said during 2021 before considering our stock price outlook for 2022 and beyond. The following are selected comments, with the date of publication and RHT.V open and close stock price on that date indicated in square brackets, and significant passages highlighted in bold:

Clean Seed Capital (CSX.V)

Clean Seed Capital Group Ltd. (CSX.V) is an agricultural technologies company that offers high technology all-in-one seeding and fertilizing equipment to farmers, thereby allowing them to increase yields and lower costs. The advantages are fully outlined in their latest corporate presentation, which can be viewed here: https://www.cleanseedcapital.com/csx-2021-investor-deck-d22.pdf.

Reliq Health Technologies (RHT.V) – starting to gain real traction

RHT.V filed on November 29, 2021 (http://www.sedar.com) their consolidated financial statements and Management Discussion and Analysis for the quarter ended September 30, 2021 (Q1 FY2022), and this morning (November 30, 2021) CEO Lisa Crossley spoke to investors by webinar to review the results and projections.